Novo Nordisk Net Worth 2006-2019 | NVO

Interactive chart of historical net worth (market cap) for Novo Nordisk (NVO) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Novo Nordisk net worth as of October 18, 2019 is $124.75B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $124.746B $17.724B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $359.375B 15.53
Roche Holding AG (RHHBY) Switzerland $250.381B 0.00
Merck (MRK) United States $214.559B 17.64
Pfizer (PFE) United States $201.662B 11.88
Novartis AG (NVS) Switzerland $199.914B 17.20
Sanofi (SNY) France $116.442B 14.31
AstraZeneca (AZN) United Kingdom $115.787B 22.40
AbbVie (ABBV) United States $111.093B 8.90
GlaxoSmithKline (GSK) United Kingdom $105.929B 13.31
Eli Lilly (LLY) United States $104.711B 19.54
Bristol-Myers Squibb (BMY) United States $85.747B 12.16
Bayer (BAYRY) Germany $68.188B 9.93
H Lundbeck (HLUYY) Denmark $6.714B 9.69